Diabetic Nephropathy

• FDA label_change · 2023-06-07
  FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Macleods Pharmaceuticals Limited)

  FDA supplemental application for Losartan Potassium by Macleods Pharmaceuticals Limited, likely involving labeling changes for the generic d…

• FDA label_change · 2023-03-15
  FDA Approved: IRBESARTAN — Supplemental Application (Solco Healthcare U.S., LLC)

  FDA approved a supplemental application for IRBESARTAN from Solco Healthcare U.S., LLC, indicating a labeling change for the product.

• FDA label_change · 2021-09-10
  FDA Approved: AVAPRO — Supplemental Application (Sanofi-Aventis U.S. LLC)

  The FDA approved a supplemental labeling change for AVAPRO (irbesartan) filed by Sanofi-Aventis U.S. LLC.

• FDA label_change · 2020-05-19
  FDA Approved: CAPTOPRIL — Supplemental Application (Solco Healthcare US, LLC)

  The FDA approved a supplemental application for captopril submitted by Solco Healthcare US, LLC, updating the labeling for the generic drug …

• FDA label_change · 2016-02-18
  FDA Approved: LISINOPRIL — Supplemental Application (Exelan Pharmaceuticals Inc.)

  The FDA approved a supplemental application for lisinopril submitted by Exelan Pharmaceuticals Inc., typically resulting in labeling updates…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA label_change · 2015-07-27
  FDA Approved: DIOVAN — Supplemental Application (Novartis Pharmaceuticals Corporation)

  FDA approved a supplemental application for DIOVAN (valsartan) submitted by Novartis Pharmaceuticals Corporation, resulting in changes to th…

• FDA label_change · 2008-08-14
  FDA Approved: ENALAPRIL MALEATE — Supplemental Application (Amici Pharma, Inc)

  FDA approved a supplemental application for enalapril maleate from Amici Pharma, Inc., resulting in labeling changes for the product.